-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Donaperminogene Seltoplasmid in Diabetic Neuropathic Pain
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Donaperminogene seltoplasmid in Diabetic Neuropathic Pain Drug Details: Donaperminogene seltoplasmid (VM-202) is under development...
-
Product Insights
Schwedt refinery
Schwedt refinery is located in Brandenburg, Germany. It started operations in 1964. The refinery is operated by PCK Raffinerie GmbH. Empower your strategies with our Schwedt refinery report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance....
-
Company Profile
Helixmith Co Ltd – Company Profile
Helixmith Co Ltd (Helixmith), discovers and develops DNA, protein-based therapeutics, herbal medicines and nutraceuticals for treating various ischemic diseases or neurodegenerative disorders. The company developed Engensis (VM202), a plasmid DNA therapy used to express two isoforms of hepatocyte growth factor and treat various neurodegenerative diseases such as diabetic peripheral neuropathy, diabetic foot ulcer and coronary artery disease. It develops a VM206 program for treating breast cancer and a VM501 program against thrombocytopenia, a deficiency of blood platelets caused due to...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – donaperminogene seltoplasmid
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry donaperminogene seltoplasmid Drug Details Donaperminogene seltoplasmid (VM-202) is under development for the treatment of...
-
Sector Analysis
Germany Crude Oil Refinery Outlook to 2022
Germany Crude Oil Refinery Outlook to 2022 is a comprehensive report on crude oil refinery industry in Germany. The report provides oil production, consumption, exports and imports details from 2010 to 2022 along with oil reserves for the period 2010 to 2016. The report also provides details on oil refineries such as name, type, operational status, operator apart from capacity data for the major processing units, for all active refineries in Germany for the period 2012–2022. Further, the report also...